Page last updated: 2024-10-27

gabexate and Extravasation of Contrast Media

gabexate has been researched along with Extravasation of Contrast Media in 1 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Research Excerpts

ExcerptRelevanceReference
"A 64-year-old man was diagnosed with acute myeloid leukemia (AML) complicated by disseminated intravascular coagulation."1.35Leukemia cutis originating in the extravasation site of i.v. gabexate mesilate infusion. ( Aota, Y; Iguchi, T; Kurashige, Y; Miyakura, T; Nagai, A; Tsuboi, R; Yamamoto, T, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miyakura, T1
Yamamoto, T1
Kurashige, Y1
Nagai, A1
Iguchi, T1
Aota, Y1
Tsuboi, R1

Other Studies

1 other study available for gabexate and Extravasation of Contrast Media

ArticleYear
Leukemia cutis originating in the extravasation site of i.v. gabexate mesilate infusion.
    The Journal of dermatology, 2008, Volume: 35, Issue:1

    Topics: Anticoagulants; Disseminated Intravascular Coagulation; Extravasation of Diagnostic and Therapeutic

2008